Stockscreener 앱 받기
0.1237
32.50%
-0.0594
시간 외 거래:
.12
-0.0037
-2.99%
전일 마감가:
$0.1831
열려 있는:
$0.1258
하루 거래량:
160.22M
Relative Volume:
1.82
시가총액:
$6.89M
수익:
-
순이익/손실:
$-56.98M
주가수익비율:
-0.1015
EPS:
-1.2189
순현금흐름:
$-38.98M
1주 성능:
+24.85%
1개월 성능:
+16.06%
6개월 성능:
-93.94%
1년 성능:
-87.88%
1일 변동 폭
$0.1161
$0.1589
1주일 범위
$0.0875
$0.3843
52주 변동 폭
$0.08
$4.5499
Quince Therapeutics Inc Stock (QNCX) Company Profile
명칭
Quince Therapeutics Inc
전화
415-910-5717
주소
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Compare QNCX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
0.1237 | 10.20M | 0 | -56.98M | -38.98M | -1.2189 |
VRTX
Vertex Pharmaceuticals Inc
|
446.74 | 112.92B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
767.85 | 81.99B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
800.50 | 48.82B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.28 | 43.66B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.42 | 34.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-08-05 | 개시 | Citizens JMP | Mkt Outperform |
| 2025-03-24 | 개시 | Oppenheimer | Outperform |
Quince Therapeutics Inc 주식(QNCX)의 최신 뉴스
Quince Therapeutics Announces 1-for-10 Reverse Stock Split - TipRanks
Quince Therapeutics, Inc. Files Form 8-K Announcing Certificate of Amendment and Company Details - Minichart
Quince Therapeutics to implement 1-for-10 reverse stock split effective Friday - Investing.com
Quince Therapeutics (QNCX) enacts 1-for-10 reverse split, 16.3M shares post-split - Stock Titan
History Review: Is Quince Therapeutics Inc stock overvalued or fairly pricedEarnings Recap Summary & Weekly Setup with ROI Potential - baoquankhu1.vn
$Quince Therapeutics (QNCX.US)$ goodluck guy - Moomoo
$Quince Therapeutics (QNCX.US)$ mon stop fight it - Moomoo
$Quince Therapeutics (QNCX.US)$ thank clear - Moomoo
Plays for 4-08-2026 $BTC Digital (BTCT.US)$ $Quince Therapeutics (QNCX.US)$ - Moomoo
Trending Stocks Today | U Power Surges 59.06% Post-Market - Moomoo
$Quince Therapeutics (QNCX.US)$ LFG! - Moomoo
QNCX PE Ratio & Valuation, Is QNCX Overvalued - Intellectia AI
Quince Therapeutics Inc expected to post a loss of 22 cents a shareEarnings Preview - TradingView
Quince Therapeutics settles $16.4M debt with $5.5M payment - MSN
QNCX Stock Price, Quote & Chart | QUINCE THERAPEUTICS INC (NASDAQ:QNCX) - ChartMill
Quince Therapeutics Delays Annual 10-K Filing - TipRanks
Quince Therapeutics (QNCX) delays 2025 10-K after failed Phase 3; seeks 15-day extension - Stock Titan
QNCX Stock News Today | Earnings, Events & Price Alerts - intellectia.ai
Aug Setups: Will Quince Therapeutics Inc benefit from AI trends2026 Earnings & Fast Moving Trade Plans - baoquankhu1.vn
Quince Therapeutics settles $16.4M debt for $5.5M payment By Investing.com - Investing.com South Africa
Quince Therapeutics (QNCX) Resolves Debt with European Investmen - GuruFocus
Quince Therapeutics Settles $16.4 Million in Debt - National Today
Curious about the most active stocks on Monday? - ChartMill
Quince Therapeutics settles EIB loan obligations for $5.5 mln - marketscreener.com
Quince Therapeutics Settles EIB Loan Obligations For $5.5 Mln - TradingView
Stocks Under $0.10: ITRM, AMLM, BFRG, QNCX, ADMQ March Madness Watch - openpr.com
Quince Therapeutics settles approximately $16.4 million of debt - marketscreener.com
Quince Therapeutics Settles $16.4 Million Debt for $5.5 Million, Advances Strategic Restructuring - minichart.com.sg
Quince Therapeutics Eliminates EIB Debt, Boosts Flexibility - TipRanks
Quince Therapeutics, Inc. Settles Approximately $16.4 Million of Debt - marketscreener.com
Why did QNCX stock surge 40% in pre-market today? - MSN
Quince Therapeutics settles $16.4M debt for $5.5M payment - Investing.com
Quince Therapeutics Settles EIB Finance Contract With €4.8M Payment, Ending 2020 Facility - TradingView
Quince Therapeutics (QNCX) retires about $16.4M EIB loan with $5.5M payment - Stock Titan
A $5.5M payment erased Quince debt as it explores merger options - Stock Titan
Quince Therapeutics Settles Approximately $16.4 Million of Debt - Business Wire
Highs Report: Can Quince Therapeutics Inc sustain its profitabilityDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Quince Therapeutics stock extends rally on strategic review - MSN
Published on: 2026-03-22 07:39:28 - baoquankhu1.vn
Quince Therapeutics Faces Nasdaq Listing Compliance Deficiencies - The Globe and Mail
Quince Therapeutics receives Nasdaq notices for bid price and market value - Investing.com UK
Quince Therapeutics receives Nasdaq notices for bid price and market value By Investing.com - Investing.com South Africa
Form 8K Quince Therapeutics Inc For: 20 March By Investing.com - Investing.com
Quince Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Quince Therapeutics (QNCX) hit with dual Nasdaq listing deficiency notices - Stock Titan
U.S. Earnings Preview: After Market Close March 20 - news.futunn.com
QNCX stock down 9.59% intraday (NASDAQ) March 20 2026: earnings week in focus - Meyka
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Bear Alert: Is now the right time to enter Quince Therapeutics IncWeekly Trade Analysis & Technical Confirmation Trade Alerts - baoquankhu1.vn
QNCX Quince Therapeutics (NASDAQ) $0.099 intraday 18 Mar 2026: earnings Mar 23 could reset outlook - Meyka
Quince Therapeutics Inc (QNCX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.91%
2.08%
자본화:
|
볼륨(24시간):